Møre and Romsdal Hospital Molde
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Müller, Bernd
CandMig-3, NCT04574713: Candesartan for Migraine Prevention:

Active, not recruiting
2
450
Europe
Candesartan Oral Tablet 8 mg, Candesartan Oral Tablet 16 mg, Placebo oral tablet
St. Olavs Hospital, Norwegian University of Science and Technology, Nordlandssykehuset HF, Molde Hospital, Haukeland University Hospital, Sorlandet Hospital HF, University Hospital, Akershus, Ullevaal University Hospital, Rikshospitalet University Hospital, University Hospital of North Norway, Tartu University Hospital
Migraine
04/24
10/24

Download Options